Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.86−0.53 (-5.64%)
Close on Nov 12, 2026Market cap $457.46MP/E –Yield –
Helus Pharma r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was C$54.91M, up 69.7% from the year before. The highest annual figure on record is C$54.91M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | C$54.91M | +69.7% |
| FY2024 | Mar 31, 2024 | C$32.36M | +27.0% |
| FY2023 | Mar 31, 2023 | C$25.49M | +45.0% |
| FY2022 | Mar 31, 2022 | C$17.59M | +432.9% |
| FY2021 | Mar 31, 2021 | C$3.30M | – |
See a number that looks wrong?